Slides Airfinity – 5th GLOBAL BIOPHARMA CEO / TOP EXECS VIRTUAL PRESS BRIEFING

Position paper 18 Apr 2024

How we are contributing to global pharmaceutical standards

The evolving global pharmaceutical regulatory environment and the increasing interest of new countries in joining the ICH highlights the importance of maintaining consistent interpretation and implementation of ICH guidelines among industry and regulatory authorities worldwide. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), along with other ICH Members and Observers, has an important role...

The socio-economic value of adult immunisation programmes

Download this OHE report, commissioned by IFPMA, to learn more about the socio-economic value of adult vaccination programems on individual lives and societies at large.

Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda

On 9 April 2024, IFPMA, Interfarma, and FIFARMA submitted an open letter to G20 Ministers in support of the advancement of the G20 Health Agenda. The letter is available for download in English, Portuguese, and Spanish.